Early Detection Diagnostics
Early detection and diagnostics play a crucial role in improving cancer outcomes by identifying the disease at its earliest, most treatable stages. Advances in imaging, blood tests, and biomarker analysis enhance accuracy, leading to timely interventions and better survival rates.
New blood test could detect gallbladder cancer more accurately
Scientists at Karolinska Institutet and Karolinska University Hospital have discovered specific proteins in the blood that can help doctors distinguish between gallbladder cancer and gallbladder inflammation.
How genetic testing is leading to better treatments for childhood cancer
New research is bringing hope to children and young people with cancer by using genetic testing to match them with more effective and less harmful treatments.
Genetic testing offers hope for targeted childhood cancer therapies
New research has looked into a comprehensive and structured approach to genetic testing, matching children and young people with cancer to targeted treatments.
Cell-free RNA blood test identifies early-stage cancers, monitors treatment resistance and detects tissue damage
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions.
DNA origami offers more accurate imaging in the fight against pancreatic cancer
One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue
New genetic code may be the key in understanding origins of ovarian cancer, new treatment options
ICHMOND, Va. (WRIC) — A group of scientists at Virginia Commonwealth University (VCU) may have the key to discovering cancer’s origins within the body, as well as insights into new treatment strategies for ovarian cancer.
New NHS blood test can pick up 12 types of cancers
A blood test that can detect cancer before symptoms develop is being assessed for potential NHS use, health officials have said.
The unseen team of medical detectives at Northwestern Medicine using advanced techniques for cancer detection, treatment
CHICAGO (WGN) — While machines can scan and surgeons cut, it takes a special kind of doctor to determine the presence of cancer in a patient.
Scientists develop powerful blood test method to detect and track cancer
A new study has revealed a promising method that could one day allow doctors to detect and monitor cancer using only blood tests.
Unique Stanford Medicine-designed AI predicts cancer prognoses, responses to treatment
A new artificial intelligence tool developed at Stanford Medicine combines data from medical images with text to predict cancer prognoses and treatment responses.
RNT Health Insights Receives Second US FDA Breakthrough Device Designation for Esophageal Cancer Detection Tool
Chandigarh [India], January 9: RNT Health Insights, a Chandigarh-based health-tech startup specializing in AI-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, has been granted its second US FDA Breakthrough Device Designation for its Esophageal Cancer detection tool.
AI diagnoses endometrial cancer with near perfect accuracy
One of Australia’s most common gynecological cancers could be detected sooner and more accurately thanks to a specialized artificial intelligence (AI) model, new research shows.
Chinese doctors make major breakthrough in stomach cancer detection
Doctors from Shanghai Renji Hospital have discovered for the first time in the world that an elevated presence of two types of streptococcus in a person’s feces may indicate a high risk for stomach cancer, potentially aiding in the early detection of the disease, the hospital said on Wednesday.
This AI is creating cancer-killing molecules
The hunt for cancer-combatting antibodies normally relies upon human lab scientists combing through vast amounts of data. LabGenius’ automated AI robotic system has disrupted that process.
MicroRNA-Based Germline Signature Predicts RT-Induced Genitourinary Toxicity in Prostate Cancer
FRIDAY, April 18, 2025 (HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is valid for predicting radiotherapy (RT)-induced genitourinary (GU) toxicity in patients with prostate cancer, according to a study
Deadliest Catch Star Captain “Wild” Bill Wichrowski’s Cancer Journey Is an Inspiring Tale
Despite being a season apart, Captain “Wild” Bill Wichrowski was forced to leave the Season 20 crabbing season early for cancer treatment.
Deadliest Catch Star Captain “Wild” Bill Wichrowski’s Cancer Journey Is an Inspiring Tale
Despite being a season apart, Captain “Wild” Bill Wichrowski was forced to leave the Season 20 crabbing season early for cancer treatment.
Scientists discover lung cancer weakness that could prevent relapse
Scientists have discovered a new weakness in lung cancer that could lead to better treatments and help prevent the disease from coming back.
Precision Medicine for Prostate Cancer
AI can help patients decide whether active surveillance is right for them
A new AI tool could slash cancer drug research waiting times in half
AI technology developed by a team at The Institute of Cancer Research may be able to streamline the years-long drug discovery process
AI in colonoscopy can improve cancer detection
New research led by a Norwegian team has found that using artificial intelligence (AI) during colonoscopy screenings can slightly improve the detection of small growths called polyps. These are important to find because they can turn into cancer over time.
In a first, scientists develop drug candidates to target untreatable cancer protein
Using an innovative screening method, the researchers discovered peptides—short chains of amino acids—that can irreversibly inhibit this cancer protein within cells
Research reveals worse outcomes for men who avoid prostate cancer screening
Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research identifying a new high-risk group.
Cancer-keeper genes offer targets for disrupting cancer cell maintenance
By analyzing huge amounts of biological data, the use of machine learning accelerates the identification of critical control hubs that are sensitive to changes in the network structure of the total controllability network, thereby having potential as diagnostic biomarkers and therapeutic targets for disease and cancer treatment.
